生物
泛素
脱氮酶
重编程
癌细胞
癌症
细胞生物学
转录因子
细胞
生物化学
遗传学
基因
作者
Tianshui Sun,Zhuonan Liu,Qing Yang
出处
期刊:Molecular Cancer
[BioMed Central]
日期:2020-10-01
卷期号:19 (1): 146-146
被引量:494
标识
DOI:10.1186/s12943-020-01262-x
摘要
Abstract Metabolic reprogramming, including enhanced biosynthesis of macromolecules, altered energy metabolism, and maintenance of redox homeostasis, is considered a hallmark of cancer, sustaining cancer cell growth. Multiple signaling pathways, transcription factors and metabolic enzymes participate in the modulation of cancer metabolism and thus, metabolic reprogramming is a highly complex process. Recent studies have observed that ubiquitination and deubiquitination are involved in the regulation of metabolic reprogramming in cancer cells. As one of the most important type of post-translational modifications, ubiquitination is a multistep enzymatic process, involved in diverse cellular biological activities. Dysregulation of ubiquitination and deubiquitination contributes to various disease, including cancer. Here, we discuss the role of ubiquitination and deubiquitination in the regulation of cancer metabolism, which is aimed at highlighting the importance of this post-translational modification in metabolic reprogramming and supporting the development of new therapeutic approaches for cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI